Pfizer (PFE) is a publicly traded Healthcare sector company. As of September 16, 2026, PFE trades at $27.61 with a market cap of $157.99B and a P/E ratio of 36.20. PFE moved +0.20% today. Year to date, PFE is +10.64%; over the trailing twelve months it is +14.94%. Its 52-week range spans $20.92 to $29.21. Analyst consensus is buy with an average price target of $28.57. Rallies surfaces PFE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Pfizer (PFE) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PFE moved +0.20% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $27.61 |
| Market Cap | $157.99B |
| P/E Ratio | 36.20 |
| EPS | $0.76 |
| Dividend Yield | 0.43% |
| 52-Week High | $29.21 |
| 52-Week Low | $20.92 |
| Volume | 36.69K |
| Avg Volume | 0 |
| Revenue (TTM) | $63.70B |
| Net Income | $4.37B |
| Gross Margin | 73.18% |
21 analysts cover PFE: 0 strong buy, 7 buy, 13 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $28.57.